Publications by authors named "Andrew Weiskopf"

Claim this Profile
M
Metabolism of selective 20-epi-vitamin D analogs in rat osteosarcoma UMR-106 cells: Isolation and identification of four novel C-1 fatty acid esters of 1α,25-dihydroxy-16-ene-20-epi-vitamin D.
Caroline Ceailles Flarakos, Andrew Weiskopf, Matthew Robinson, Guoshun Wang, Paul Vouros

Steroids· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Conformational Analysis of Protein Drugs in Formulation by Hydrogen/Deuterium Exchange Mass Spectrometry.
Zeinab E Nazari, Marco van de Weert, George Bou-Assaf, Damian Houde, Andrew Weiskopf

J Pharm Sci· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conformational Analysis of Proteins in Highly Concentrated Solutions by Dialysis-Coupled Hydrogen/Deuterium Exchange Mass Spectrometry.
Damian Houde, Zeinab E Nazari, George M Bou-Assaf, Andrew S Weiskopf, Kasper D Rand

J Am Soc Mass Spectrom· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technical Decision-Making with Higher Order Structure Data: Detecting Reversible Concentration-Dependent Self-Association in a Monoclonal Antibody and a Preliminary Investigation to Eliminate It.
Julie Y Wei, George M Bou-Assaf, Damian Houde, Andrew Weiskopf

J Pharm Sci· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis.
Vincent Corvari, Linda O Narhi, Thomas M Spitznagel, Nataliya Afonina, Shawn Cao, Andrew Weiskopf

Biologicals· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy.
Linda O Narhi, Vincent Corvari, Dean C Ripple, Nataliya Afonina, Irene Cecchini, Andrew Weiskopf

J Pharm Sci· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Size-exclusion chromatography-mass spectrometry with m-nitrobenzyl alcohol as post-column additive for direct characterization of size variants of monoclonal antibodies.
Chong-Feng Xu, Li Zang, Andrew Weiskopf

J Chromatogr B Analyt Technol Biomed Life Sci· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phthalide with in vitro growth inhibitory activity from an oidiodendron strain.
Erin L Mullady, William P Millett, Hye-Dong Yoo, Andrew S Weiskopf, Jianxin Chen

J Nat Prod· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis